Tag: bioequivalence challenges

Cancer Medication Combinations: Why Generic Bioequivalence Is Harder Than You Think

Generic cancer medications save billions yearly but struggle with combination therapies due to hidden bioequivalence risks. Learn how regulators, providers, and patients navigate these challenges balancing safety and access.